Alnara Pharmaceuticals Bookmark and Share

ArticleDateSource
FDA rejects Lilly, Alnara CF drug April 18, 2011Health News - BizJournals.com
Eli Lilly and Company acquires Alnara PharmaceuticalsJuly 21, 2010Pharmaceutical - Moreover
Buying Into a New Model – Lilly's Alnara AcquisitionJuly 21, 2010Contract Pharma
Eli Lilly and Company Pays up to $380M for Alnara Pharmaceuticals, Inc. July 21, 2010BioSpace - Breaking News
Lilly Announces Completion of Alnara AcquisitionJuly 20, 2010Pharma News - PR Newswire
Alnara Pharma Used “Flexible” Strategy on Road to Eli Lilly DealJuly 08, 2010Xconomy Life Sciences
Eli Lilly and Company To Buy Drug Developer Alnara Pharmaceuticals, Inc. July 06, 2010BioSpace
Latham & Watkins Reps Eli Lilly In Alnara AcquisitionJuly 03, 2010Biotechnology - Moreover
Lilly Acquires Biotech Drug Developer Alnara PharmaceuticalsJuly 02, 2010Biotechnology - Moreover
Alnara to be bought by Eli LillyJuly 02, 2010Pharmaceutical - Moreover
Lilly buys Alnara for undisclosed sumJuly 02, 2010FierceBiotech
Lilly to Acquire Alnara PharmaceuticalsJuly 02, 2010Biotech News - PR Newswire
Drug Giant Eli Lilly Buys Alnara Pharma To Get Cystic Fibrosis DrugJuly 02, 2010Xconomy Life Sciences
Alnara rises from Altus' ashesMarch 05, 2010FierceBiotech
Alnara Pharmaceuticals, Inc. Flourishes from Altus Pharmaceuticals Inc. Demise March 05, 2010BioSpace - Breaking News
Alnara Pharmaceuticals Expands Leadership Team and Scientific Advisory BoardFebruary 25, 2010Pharma News - Business Wire
Alnara Therapeutics, Inc.: Series B $35MFebruary 23, 2010OnBioVC
Alnara Pharmaceuticals Reports Receiving $35 Million in Series B Round of FinancingFebruary 03, 2010Pharmaceutical - Moreover
Alnara Pharmaceuticals Secures $35 Million in FinancingFebruary 02, 2010Pharmaceutical - Moreover
Alnara Adds $35M, Harvest Power Teams Up with Waste Management, & More Boston-Area Deals NewsJanuary 29, 2010Xconomy Life Sciences
Alnara Pharmaceuticals raises $35 million in Series B financingJanuary 28, 2010Pharmaceutical - Moreover
Alnara Pharma closes $35M VC roundJanuary 28, 2010Health News - BizJournals.com
Alnara grabs $35M in VC cash as it aims at NDAJanuary 28, 2010FierceBiotech
Alnara Scores $35M to Push NDA Filing for Nonporcine Pancreatic Enzyme Replacement TherapyJanuary 28, 2010GEN News Highlights
Alnara Pharmaceuticals, Inc. Secures $35 Million in Series B Round January 28, 2010BioSpace
Alnara Pharmaceuticals Secures $35 Million in Series B RoundJanuary 28, 2010Pharma News - Business Wire
Alnara Bags $35M B Round, Plans to Seek FDA Approval for Cystic Fibrosis DrugJanuary 28, 2010Xconomy Life Sciences



View all the latest news